ELOXATIN® is becoming a cornerstone therapy for the treatment of metastatic colorectal cancer in Europe | Oxaliplatin – Eloxatin® – Elplat® | / | Press Releases

Menu Content/Inhalt

Home|Careers|Contact us

Social responsibility

Development capabilites

Commercial Products

News

Oxaliplatin – Eloxatin® – Elplat®

PRESS RELEASES

ELOXATIN® is becoming a cornerstone therapy for the treatment of metastatic colorectal cancer in Europe

Link to Sanofi-Synthelabo's press release of January 7th, 2004